About
Novel treatments for gastrointestinal diseases and disorders
Areas of Focus
Categories
Small Molecule PharmaceuticalNJ, NY, PA
Clinical Trials (14)
View allTotal Trials
14
As Lead Sponsor
14
As Collaborator
0
Total Enrollment
4,292
By Phase
PHASE2: 2PHASE1: 8PHASE3: 3
By Status
COMPLETED: 11NOT_YET_RECRUITING: 1RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline14 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
Today
Hover over trial bars to see details
Recent Trials
NCT06851559Lead Sponsor
A Study in Adult Participants With EoE to Evaluate Vonoprazan 20 mg Compared to Placebo After 12 Weeks and to Evaluate Vonoprazan 20 mg Up to 24 Weeks
PHASE2Not yet recruiting
80 participants
Started: Dec 31, 2025 · Completed: Mar 31, 2027
NCT06660342Lead Sponsor
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
N/ARecruiting
728 participants
Started: May 15, 2025 · Completed: Sep 30, 2034
NCT06831344Lead Sponsor
A Study to Evaluate Two Vonoprazan Orally Disintegrating Tablet Formulations Administered Without Water or Mixed With Water and Administered Via a Syringe Relative to the Vonoprazan Tablet in Healthy Participants
PHASE1Completed
25 participants
Started: Feb 14, 2025 · Completed: Apr 10, 2025
NCT06391177Lead Sponsor
A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily
PHASE1Completed
15 participants
Started: May 7, 2024 · Completed: Sep 19, 2024
NCT06106022Lead Sponsor
A Study to Evaluate Vonoprazan in Children Who Have Symptomatic Gastroesophageal Reflux Disease
PHASE1Completed
22 participants
Started: Nov 1, 2023 · Completed: Apr 29, 2024
Locations (1)
Headquarters
Florham Park, NJ, United States
Map
Loading map...